Clinical Translational Core (CTC)
临床转化核心(CTC)
基本信息
- 批准号:10239465
- 负责人:
- 金额:$ 22.86万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-22 至 2026-05-31
- 项目状态:未结题
- 来源:
- 关键词:Adaptive BehaviorsAnimal BehaviorAreaBasic ScienceBehavioralBiologicalBiological AssayBiological MarkersBiologyBiometryBloodBlood specimenBostonCell LineCellsChild CareChild PsychiatryClinicClinicalClinical ResearchClinical TrialsClinical Trials DesignCognitiveCollaborationsCollectionComplexConsultationsDNAData AnalysesDevelopmentDiagnosisDisciplineDiscriminationDiseaseDown SyndromeDrug ScreeningElectroencephalographyEnsureEnvironmentEquipmentEvent-Related PotentialsFaceFamilyFibroblastsFosteringFragile X SyndromeFutureGenerationsGeneticGoalsGrowthHumanHuman ResourcesImageImprove AccessIndividualInfrastructureInstitutional PolicyIntellectual and Developmental Disabilities Research CentersIntellectual functioning disabilityInterventionIntervention TrialLanguageMusNatural HistoryNeurodevelopmental DisorderNeurofibromatosesNeuronal DifferentiationNeuronsNeurophysiology - biologic functionNeuropsychological TestsNeuropsychologyNeurosciencesParentsParticipantPatient CarePatient RecruitmentsPatientsPediatric HospitalsPediatric NeurologyPhenotypePhysiologicalPhysiologyPopulationPositioning AttributePre-Clinical ModelPreparationProcessRegistriesResearchResearch PersonnelResearch SupportResourcesRett SyndromeSamplingScientistServicesSiblingsTechnical ExpertiseTestingTherapeuticTissuesTrainingTranslatingTranslational ResearchTuberous sclerosis protein complexWorkbasebench to bedsidebiobankbiomarker developmentbiomarker performancecellular imagingclinical careclinical phenotypecohortcommunity engagementdensitydesigngenetic analysishigh throughput screeninghuman diseaseinduced pluripotent stem cellmouse modelmultidisciplinaryneurobehavioralneurophysiologynext generationnovelnovel diagnosticsnovel therapeutic interventionpatient advocacy grouppre-clinicalpre-clinical researchprogramsprotocol developmentrare genetic disorderscreeningsocialsuccesstooltranslational neurosciencetranslational studytreatment trial
项目摘要
CLINICAL TRANSLATIONAL CORE
ABSTRACT
The objectives of the Clinical Translational Core (CTC) of our IDDRC are to accelerate the translation of
research discoveries into new treatments for neurodevelopmental disorders, through collaboration with basic
scientists and clinicians, as well as to train future leaders in translational neuroscience. Services offered by the
Clinical Translational Core to support translational work include three sub-cores: 1) Patient-based Preclinical
Services, comprised of a Biorepository and the induced pluripotent stem cell (iPSC) based Human Neuron
Unit, 2) Clinical Phenotyping Services, consisting of the Neurobehavioral Unit and the Neurophysiology Unit,
and 3) Clinical Trial and Regulatory Services, containing the Regulatory Unit and Research Participant
Registry. The suite of services offered by the CTC enables investigators to pursue an integrated approach to
therapeutic discovery for neurodevelopmental disorders, from patient derived samples in preclinical research to
biomarker development to natural history and interventional clinical trials. Sub-core 1 - Patient Based
Preclinical Services - maintains the regulatory approval to collect patient samples that can be used for primary
research or for the generation of iPSC lines and neuronal differentiation within the Human Neuron Unit. Sub-
core 2 - Clinical Phenotyping Services - provides expertise and access to high density EEG equipment as well
as direct phenotyping through neuropsychological assessment and neurophysiological recording. Sub-core 3 -
Clinical Trial and Regulatory Services - provides expert consultation in the regulatory framework supporting
clinical research which enables both the services provided within the Core and IDDRC investigators of all
backgrounds. To facilitate engagement in clinical research by basic science researchers and young
investigators, the sub-core assists in the preparation of regulatory documents, the training of study staff,
patient recruitment and data analysis. Patient recruitment is supported by the Research Participant Registry, a
collection of over 30,000 individuals willing to participate in clinical research, including patients with a myriad of
neurodevelopmental diagnoses, their parents and siblings, and typically developing controls. To ensure that
the efforts of the Core are focused in areas that will produce meaningful benefits for the intellectual and
developmental disability population, the Core is strongly connected to clinical care centers and patient
advocacy groups, both of which advise the activity and development of the group. Through these efforts, the
Core has a proven record of success in designing and launching preclinical translational and clinical projects
for IDDRC investigators.
临床翻译核心
摘要
我们IDDRC的临床翻译核心(CTC)的目标是加速以下内容的翻译:
研究发现神经发育障碍的新疗法,通过与基础
科学家和临床医生,以及培养未来的领导者在转化神经科学。提供的服务
支持翻译工作的临床翻译核心包括三个子核心:1)基于患者的临床前
服务,包括生物储存库和基于人类神经元的诱导多能干细胞(iPSC)
2)临床表型分析服务,由神经行为科和神经生理科组成,
和3)临床试验和监管服务,包括监管部门和研究参与者
注册表反恐中心提供的一整套服务使调查人员能够采取综合办法,
神经发育障碍的治疗发现,从临床前研究中的患者来源样本到
生物标志物开发到自然史和干预性临床试验。子核心1 -基于患者
临床前服务-保持监管批准,以采集可用于主要研究的患者样本
研究或用于iPSC系的产生和人类神经元单元内的神经元分化。亚-
核心2 -临床表型分析服务-提供专业知识,并获得高密度EEG设备以及
作为通过神经心理学评估和神经生理学记录的直接表型。次级核心3 -
临床试验和监管服务-提供监管框架方面的专家咨询,
临床研究,使核心和IDDRC研究者提供的服务,
背景促进基础科学研究人员和年轻人参与临床研究
研究者,子核心协助编写监管文件,培训研究人员,
患者招募和数据分析。患者招募由研究参与者登记处支持,
收集了超过30,000名愿意参与临床研究的人,包括患有各种疾病的患者。
神经发育诊断,他们的父母和兄弟姐妹,通常发展控制。确保
核心的努力集中在将为知识和
发展残疾人口,核心是密切联系的临床护理中心和病人
倡导团体,这两个团体都为该团体的活动和发展提供咨询意见。通过这些努力,
Core在设计和启动临床前转化和临床项目方面有着成功的记录
IDDRC调查员的
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MUSTAFA SAHIN其他文献
MUSTAFA SAHIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MUSTAFA SAHIN', 18)}}的其他基金
Disrupted ciliary signaling in the brain pathology of Tuberous Sclerosis Complex (Diversity Supplement)
结节性硬化症脑部病理学中纤毛信号传导中断(多样性补充剂)
- 批准号:
10516328 - 财政年份:2022
- 资助金额:
$ 22.86万 - 项目类别:
Purchase of a high-density electroencephalography (EEG) and neuromodulation system for use in an institutional core facility
购买高密度脑电图 (EEG) 和神经调节系统用于机构核心设施
- 批准号:
10283029 - 财政年份:2021
- 资助金额:
$ 22.86万 - 项目类别:
Disrupted ciliary signaling in the brain pathology of Tuberous Sclerosis Complex
结节性硬化症脑病理学中纤毛信号传导中断
- 批准号:
9975242 - 财政年份:2019
- 资助金额:
$ 22.86万 - 项目类别:
Disrupted Ciliary Signaling in the Brain Pathology of Tuberous Sclerosis Complex
结节性硬化症脑病理学中纤毛信号传导中断
- 批准号:
10408824 - 财政年份:2019
- 资助金额:
$ 22.86万 - 项目类别:
Disrupted Ciliary Signaling in the Brain Pathology of Tuberous Sclerosis Complex
结节性硬化症脑病理学中纤毛信号传导中断
- 批准号:
10654265 - 财政年份:2019
- 资助金额:
$ 22.86万 - 项目类别:
Developmental Synaptopathies Associated with TSC, PTEN and SHANK3 Mutations
与 TSC、PTEN 和 SHANK3 突变相关的发育性突触病
- 批准号:
9335190 - 财政年份:2014
- 资助金额:
$ 22.86万 - 项目类别:
Developmental Synaptopathies Associated with TSC, PTEN and SHANK3 Mutations
与 TSC、PTEN 和 SHANK3 突变相关的发育性突触病
- 批准号:
9804358 - 财政年份:2014
- 资助金额:
$ 22.86万 - 项目类别:
Developmental Synaptopathies Associated with TSC, PTEN and SHANK3 Mutations Administrative Core
与 TSC、PTEN 和 SHANK3 突变相关的发育性突触病管理核心
- 批准号:
10242078 - 财政年份:2014
- 资助金额:
$ 22.86万 - 项目类别:
Developmental Synaptopathies Associated with TSC, PTEN and SHANK3 Mutations
与 TSC、PTEN 和 SHANK3 突变相关的发育性突触病
- 批准号:
10381912 - 财政年份:2014
- 资助金额:
$ 22.86万 - 项目类别:
Developmental Synaptopathies Associated with TSC, PTEN and SHANK3 Mutations Administrative Core
与 TSC、PTEN 和 SHANK3 突变相关的发育性突触病管理核心
- 批准号:
10701738 - 财政年份:2014
- 资助金额:
$ 22.86万 - 项目类别:
相似海外基金
Wireless CMOS device for observing real-time brain activity and animal behavior
用于观察实时大脑活动和动物行为的无线 CMOS 设备
- 批准号:
23K06786 - 财政年份:2023
- 资助金额:
$ 22.86万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Landscapes of fear in the Anthropocene: Linking predation risk and human disturbance to animal behavior and ecological outcomes
人类世的恐惧景观:将捕食风险和人类干扰与动物行为和生态结果联系起来
- 批准号:
RGPIN-2022-03096 - 财政年份:2022
- 资助金额:
$ 22.86万 - 项目类别:
Discovery Grants Program - Individual
The role of biological interactions in the evolution of animal behavior
生物相互作用在动物行为进化中的作用
- 批准号:
RGPIN-2019-06689 - 财政年份:2022
- 资助金额:
$ 22.86万 - 项目类别:
Discovery Grants Program - Individual
Development of Semi-Supervised Learning Method using Compressed Video for Real-Time Animal Behavior Analysis
使用压缩视频进行实时动物行为分析的半监督学习方法的开发
- 批准号:
22H03637 - 财政年份:2022
- 资助金额:
$ 22.86万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Landscapes of fear in the Anthropocene: Linking predation risk and human disturbance to animal behavior and ecological outcomes
人类世的恐惧景观:将捕食风险和人类干扰与动物行为和生态结果联系起来
- 批准号:
DGECR-2022-00323 - 财政年份:2022
- 资助金额:
$ 22.86万 - 项目类别:
Discovery Launch Supplement
Neural and molecular mechanisms of microbe-sensing in the control of animal behavior - Resubmission - 1
微生物传感控制动物行为的神经和分子机制 - 重新提交 - 1
- 批准号:
10315486 - 财政年份:2021
- 资助金额:
$ 22.86万 - 项目类别:
Neural and molecular mechanisms of microbe-sensing in the control of animal behavior - Resubmission - 1
微生物传感控制动物行为的神经和分子机制 - 重新提交 - 1
- 批准号:
10412977 - 财政年份:2021
- 资助金额:
$ 22.86万 - 项目类别:
REU Site: Animal Behavior in Context
REU 网站:背景下的动物行为
- 批准号:
2050311 - 财政年份:2021
- 资助金额:
$ 22.86万 - 项目类别:
Standard Grant
Molecular recording to predict cell fate decisions and animal behavior
分子记录预测细胞命运决定和动物行为
- 批准号:
10260139 - 财政年份:2021
- 资助金额:
$ 22.86万 - 项目类别: